Cellectar Biosciences Files 8-K on Security Holder Rights
Ticker: CLRB · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, rights
Related Tickers: CLRB
TL;DR
Cellectar (CLRB) filed an 8-K, watch for changes to security holder rights and bylaws.
AI Summary
Cellectar Biosciences, Inc. filed an 8-K on June 25, 2025, reporting material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. The filing also includes financial statements and exhibits, with the earliest event reported being June 24, 2025. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing indicates potential changes to the rights of Cellectar Biosciences' security holders and amendments to corporate governance documents, which could impact investors.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to corporate bylaws can introduce uncertainty and potential shifts in corporate control or shareholder value.
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Registrant
- June 24, 2025 (date) — Earliest event reported
- June 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 100 Campus Drive, Florham Park, NJ, 07932 (address) — Business and mail address
FAQ
What specific modifications were made to the rights of Cellectar Biosciences' security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the summary information.
What amendments were made to Cellectar Biosciences' articles of incorporation or bylaws?
The 8-K filing states that there were amendments to the articles of incorporation or bylaws, but the exact nature of these amendments is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 24, 2025.
What is Cellectar Biosciences' state of incorporation and fiscal year end?
Cellectar Biosciences, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What is the primary business of Cellectar Biosciences, Inc. according to its SIC code?
According to its Standard Industrial Classification (SIC) code, Cellectar Biosciences, Inc. is in the 'PHARMACEUTICAL PREPARATIONS' industry.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding Cellectar Biosciences, Inc. (CLRB).